Browsing: Bone

BioMarin Pharmaceutical is making a significant move to strengthen its position in the rare disease market with the acquisition of Alesta Therapeutics. The deal will bring clinical-stage asset ALE1 into its pipeline. The transaction is valued at $275 million up front with an additional $215 million tied to development and regulatory milestones. It represents BioMarin’s…

We tend to lose bone mass due to drops in hormone levels after menopause, increasing the risk of osteoporosis (weak and brittle bones), which can lead to painful fractures and breaks. “The biggest risk to bones is during menopause,” confirms Rozalina G. McCoy, MD, associate professor at University of Maryland School of Medicine. “And ultimately,…

WASHINGTON — Millions of older adults take a calcium or vitamin D pill every morning, trusting it will help keep their bones strong. It’s a habit passed down for decades, backed by doctors, pharmacists and health guidelines alike. But not every long-standing health habit holds up the same way once someone goes back and checks…